Recent Progress in Terrestrial Biota-Derived Anti-Biofilm Agents for Medical Applications
creativework.keywords | anti-biofilm agents, biocidal and non-biocidal approaches, targeted stage, terrestrial biota | |
creativework.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | en |
dc.contributor.author | Vladkova T.G. | |
dc.contributor.author | Smani Y. | |
dc.contributor.author | Martinov B.L. | |
dc.contributor.author | Gospodinova D.N. | |
dc.date.accessioned | 2024-11-13T14:47:19Z | |
dc.date.accessioned | 2024-11-14T07:26:03Z | |
dc.date.available | 2024-11-13T14:47:19Z | |
dc.date.available | 2024-11-14T07:26:03Z | |
dc.date.issued | 2024-09-01 | |
dc.description.abstract | The terrestrial biota is a rich source of biologically active substances whose anti-biofilm potential is not studied enough. The aim of this review is to outline a variety of terrestrial sources of antimicrobial agents with the ability to inhibit different stages of biofilm development, expecting to give some ideas for their utilization in improved anti-biofilm treatments. It provides an update for the last 5 years on anti-biofilm plant products and derivatives, essential oils, antimicrobial peptides, biosurfactants, etc., that are promising candidates for providing novel alternative approaches to combating multidrug-resistant biofilm-associated infections. Based on the reduction in bacterial adhesion to material and cell surfaces, the anti-adhesion strategy appears interesting for the prevention of bacterial attachment in combating a broad range of mono- and multispecies bacterial biofilms. So far, few studies have been carried out in this direction. Anti-biofilm coatings made by or containing biologically active products from terrestrial biota have scarcely been studied although they are of significant interest for a reduction in infections associated with medical devices. Combination therapy with commercial antibiotics and natural products is accepted now as a promising base for future advances in anti-biofilm treatment. In vivo testing and clinical trials are necessary for clinical application. | |
dc.identifier.doi | 10.3390/applmicrobiol4030094 | |
dc.identifier.issn | 2673-8007 | |
dc.identifier.scopus | SCOPUS_ID:85205115077 | en |
dc.identifier.uri | https://rlib.uctm.edu/handle/123456789/1520 | |
dc.language.iso | en | |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85205115077&origin=inward | |
dc.title | Recent Progress in Terrestrial Biota-Derived Anti-Biofilm Agents for Medical Applications | |
dc.type | Review | |
oaire.citation.issue | 3 | |
oaire.citation.volume | 4 |